Background: The net economic value of increased health care spending remains unclear, especially for chronic diseases. Objective: To assess…
The economic value of improvements in health status
for patients with type 2 diabetes seems to exceed or equal increases
in health care…
If Congress creates a public option in health-care insurance, will that inevitably lead to a single-payer system, with the government…
A broad consensus holds that increased medical capability—technology—is the primary driver of health spending growth. However, technology…
Spending on health care in markets with a larger percentage of primary care physicians (PCPs) is lower at any point in time than is true in…
Dartmouth researchers have demonstrated that there is tremendous geographic variation in the efficiency of health care delivery systems,…
Pharmaceutical expenditures have grown rapidly in recent decades, and now total nearly 10% of health care costs. Generic drug utilization…
The article reviews the book
"Medical Research for Hire: The Political Economy of Pharmaceutical
Clinical Trials," by Jill A. Fisher.
Propensity score matching estimators (Rosenbaum and Rubin, 1983) are widely used in evaluation research to estimate average treatment…
Book abstract: Pharmaceutical policies are interlinked globally and at the same time deeply rooted in local culture. Prescribing Cultures…